CO2023005753A2 - Cápsulas de gelatina blanda de liberación modificada - Google Patents
Cápsulas de gelatina blanda de liberación modificadaInfo
- Publication number
- CO2023005753A2 CO2023005753A2 CONC2023/0005753A CO2023005753A CO2023005753A2 CO 2023005753 A2 CO2023005753 A2 CO 2023005753A2 CO 2023005753 A CO2023005753 A CO 2023005753A CO 2023005753 A2 CO2023005753 A2 CO 2023005753A2
- Authority
- CO
- Colombia
- Prior art keywords
- soft gelatin
- gelatin capsules
- dependent
- modified release
- controlled release
- Prior art date
Links
- 239000007903 gelatin capsule Substances 0.000 title abstract 3
- 230000001419 dependent effect Effects 0.000 abstract 4
- 238000013270 controlled release Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092762P | 2020-10-16 | 2020-10-16 | |
| PCT/US2021/071900 WO2022082222A1 (en) | 2020-10-16 | 2021-10-15 | Modified release softgel capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2023005753A2 true CO2023005753A2 (es) | 2023-05-29 |
Family
ID=81208677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2023/0005753A CO2023005753A2 (es) | 2020-10-16 | 2023-05-05 | Cápsulas de gelatina blanda de liberación modificada |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230390210A1 (https=) |
| EP (1) | EP4228597A4 (https=) |
| JP (1) | JP2023547062A (https=) |
| KR (1) | KR20230088388A (https=) |
| CN (1) | CN116322655A (https=) |
| AR (1) | AR123805A1 (https=) |
| AU (1) | AU2021362248A1 (https=) |
| BR (1) | BR112023006154A2 (https=) |
| CA (1) | CA3194160A1 (https=) |
| CO (1) | CO2023005753A2 (https=) |
| IL (1) | IL301715A (https=) |
| MX (1) | MX2023004418A (https=) |
| TW (1) | TW202228656A (https=) |
| WO (1) | WO2022082222A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025135085A1 (ja) * | 2023-12-22 | 2025-06-26 | 花王株式会社 | カプセル剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708834A (en) * | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US7842307B2 (en) * | 2001-08-06 | 2010-11-30 | Purdue Pharma L.P. | Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent |
| KR20100047349A (ko) * | 2001-11-22 | 2010-05-07 | 모리시타 진탄 가부시키가이샤 | 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐 |
| KR100575199B1 (ko) * | 2003-01-24 | 2006-05-02 | 알앤피코리아주식회사 | 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막 |
| IT1401313B1 (it) * | 2010-08-05 | 2013-07-18 | Perfetti Van Melle Spa | Caramelle gelatinose con ripieno fluido e metodo di ottenimento |
| US20120301546A1 (en) * | 2011-05-26 | 2012-11-29 | Hassan Emadeldin M | Acid-resistant soft gel compositions |
| GB201304662D0 (en) * | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
| GB201319792D0 (en) * | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| US20150366814A1 (en) * | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
| US20210353574A1 (en) * | 2018-10-16 | 2021-11-18 | Bayer Healthcare Llc | Softgels with solid or gel-like polymeric fill matrix |
| MX2022005050A (es) * | 2019-10-28 | 2022-07-04 | Scherer Technologies Llc R P | Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto. |
-
2021
- 2021-10-15 CA CA3194160A patent/CA3194160A1/en active Pending
- 2021-10-15 KR KR1020237015684A patent/KR20230088388A/ko active Pending
- 2021-10-15 TW TW110138424A patent/TW202228656A/zh unknown
- 2021-10-15 MX MX2023004418A patent/MX2023004418A/es unknown
- 2021-10-15 AR ARP210102856A patent/AR123805A1/es unknown
- 2021-10-15 JP JP2023523094A patent/JP2023547062A/ja active Pending
- 2021-10-15 WO PCT/US2021/071900 patent/WO2022082222A1/en not_active Ceased
- 2021-10-15 EP EP21881332.7A patent/EP4228597A4/en active Pending
- 2021-10-15 AU AU2021362248A patent/AU2021362248A1/en active Pending
- 2021-10-15 US US18/031,669 patent/US20230390210A1/en active Pending
- 2021-10-15 CN CN202180070928.5A patent/CN116322655A/zh active Pending
- 2021-10-15 BR BR112023006154A patent/BR112023006154A2/pt unknown
- 2021-10-15 IL IL301715A patent/IL301715A/en unknown
-
2023
- 2023-05-05 CO CONC2023/0005753A patent/CO2023005753A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4228597A4 (en) | 2024-10-02 |
| AU2021362248A1 (en) | 2023-06-01 |
| MX2023004418A (es) | 2023-05-04 |
| TW202228656A (zh) | 2022-08-01 |
| US20230390210A1 (en) | 2023-12-07 |
| CN116322655A (zh) | 2023-06-23 |
| KR20230088388A (ko) | 2023-06-19 |
| CA3194160A1 (en) | 2022-04-21 |
| AR123805A1 (es) | 2023-01-11 |
| WO2022082222A1 (en) | 2022-04-21 |
| JP2023547062A (ja) | 2023-11-09 |
| BR112023006154A2 (pt) | 2023-05-09 |
| IL301715A (en) | 2023-05-01 |
| AU2021362248A9 (en) | 2024-05-02 |
| EP4228597A1 (en) | 2023-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2012000217A (es) | Pastillas de gelatina blanda con nicotina | |
| CL2007002000A1 (es) | Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion. | |
| MX2009004439A (es) | Composicion de ibuprofeno. | |
| UY30905A1 (es) | Composiciones para mejorar la absorcion gastrointestinal de nutrientes y farmacos | |
| MX2013009773A (es) | Vehiculo masticable para absorcion bucal. | |
| CR11625A (es) | Formulacion de capsula | |
| CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
| CR11630A (es) | Sistema de administracion de drogas con efecto estabilizante | |
| MX384337B (es) | Composiciones farmacéuticas liofilizadas para suministro vaginal. | |
| CA3010829A1 (en) | Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof | |
| AR105203A1 (es) | Formulación oral sólida que contiene irinotecán y método de preparación de la misma | |
| CO2023005753A2 (es) | Cápsulas de gelatina blanda de liberación modificada | |
| MX2019015733A (es) | Formulacion de melatonina oralmente disoluble con agente acidificante que produce melatonina soluble en saliva. | |
| CO6321223A2 (es) | Formulacion farmaceutica solida que contiene ciclostazol | |
| CO2022019321A2 (es) | Cápsulas de gel de liberación retardada | |
| MX2019004938A (es) | Cápsula compleja que contiene esomeprazol y método de preparación de esta. | |
| AR080256A1 (es) | Formulaciones farmaceuticas solidas de ramipril y besilato de amlodipino y su preparacion | |
| AR046146A1 (es) | Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso | |
| WO2016205397A3 (en) | Target-specific delivery of therapeutic agents | |
| MX2020003697A (es) | Formulaciones farmaceuticas que comprenden un agonista del receptor opioide como ingredientes activos, metodos de fabricacion y usos terapeuticos de las mismas. | |
| MX2021002459A (es) | Formas de dosificacion en capsula disuasorias del abuso de liberacion inmediata. | |
| MD4877B1 (ro) | Compoziţie farmaceutică şi comprimat oral de S-adenozilmetionină cu eliberare întârziată | |
| ES2572180T3 (es) | Formulaciones de liberación controlada que comprenden unidad(es) discreta(s) sin recubrimiento y una matriz de liberación prolongada | |
| JOP20210135A1 (ar) | صيغة توصيل عقار قولوني | |
| MX2020006886A (es) | Sistema para suministro de medicamento. |